Ligand · LC0
LC0 · 3-({4-methoxy-5-[(4-methoxybenzyl)oxy]pyridin-2-yl}methoxy)-5-(1-methyl-1H-pyrazol-4-yl)pyrazin-2-amine
LC0, 3-({4-methoxy-5-[(4-methoxybenzyl)oxy]pyridin-2-yl}methoxy)-5-(1-methyl-1H-pyrazol-4-yl)pyrazin-2-amine (C23 H24 N6 O4, 448.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- LC0
- Formula
- C23 H24 N6 O4
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
LC0 in 2 structures; the first of them:
- 3LCO · Inhibitor Bound to A DFG-Out structure of the Kinase Domain of CSF-1R · LC0 A999 · binds LEU588, VAL596, ALA614, LYS616, GLU633, MET637, LEU640, VAL647 and 13 more
- 3LCO · Inhibitor bound to a dfg-out structure of the kinase domain of csf-1R · LC0 A999 · binds LEU588, VAL596, ALA614, LYS616, GLU633, MET637, LEU640, VAL647 and 13 more
Residues it binds most
LEU 2, GLU 2, GLY 2, VAL 2, ALA 2, ASN 2, ASP 2, CYS 2, HIS 2, ILE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.